We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHI icon
426
D.R. Horton
DHI
$41.2B
$2.12M 0.02%
19,763
-867
-4% -$104K
HPQ icon
427
HP
HPQ
$26B
$2.09M 0.01%
81,316
+495
+0.6% +$15.2K
ALL icon
428
Allstate
ALL
$70.6B
$2.09M 0.01%
18,733
-42,235
-69% -$4.61M
PWR icon
429
Quanta Services
PWR
$84.2B
$2.02M 0.01%
10,804
+647
+6% +$130K
SDGR icon
430
Schrodinger
SDGR
$1.13B
$1.98M 0.01%
70,000
-90,000
-56% -$3.63M
MNST icon
431
Monster Beverage
MNST
$95.1B
$1.96M 0.01%
37,030
+1,196
+3% +$68K
CBRE icon
432
CBRE Group
CBRE
$43.3B
$1.95M 0.01%
26,458
-99,913
-79% -$8.29M
NEM icon
433
Newmont
NEM
$96.2B
$1.95M 0.01%
52,752
-4,136
-7% -$168K
GEN icon
434
Gen Digital
GEN
$16.5B
$1.92M 0.01%
108,353
+70,400
+185% +$1.37M
U icon
435
Unity
U
$14B
$1.89M 0.01%
60,191
+9,770
+19% +$376K
SE icon
436
Sea Limited
SE
$66.4B
$1.88M 0.01%
42,868
+8,008
+23% +$392K
SBAC icon
437
SBA Communications
SBAC
$19.8B
$1.88M 0.01%
9,382
+531
+6% +$118K
NOMD icon
438
Nomad Foods
NOMD
$1.77B
$1.88M 0.01%
123,307
+8,969
+8% +$155K
DLR icon
439
Digital Realty Trust
DLR
$69.6B
$1.86M 0.01%
15,343
-2,493
-14% -$306K
GPN icon
440
Global Payments
GPN
$24.1B
$1.85M 0.01%
16,045
+485
+3% +$57.7K
INFY icon
441
Infosys
INFY
$51B
$1.85M 0.01%
108,000
+52,000
+93% +$887K
VRSN icon
442
VeriSign
VRSN
$26.3B
$1.84M 0.01%
9,068
-23
-0.3% -$4.78K
DVN icon
443
Devon Energy
DVN
$51.3B
$1.83M 0.01%
38,357
-1,972
-5% -$99.3K
WBD icon
444
Warner Bros
WBD
$64.3B
$1.82M 0.01%
167,247
+35,671
+27% +$445K
RF icon
445
Regions Financial
RF
$26.4B
$1.81M 0.01%
104,983
+7,168
+7% +$136K
RDY icon
446
Dr. Reddy's Laboratories
RDY
$9.8B
$1.81M 0.01%
135,000
+25,000
+23% +$338K
BR icon
447
Broadridge
BR
$18.4B
$1.79M 0.01%
9,985
-2,560
-20% -$453K
IT icon
448
Gartner
IT
$11.1B
$1.78M 0.01%
5,174
-5,629
-52% -$1.96M
CTVA icon
449
Corteva
CTVA
$60.5B
$1.78M 0.01%
34,720
-18,862
-35% -$999K
CFG icon
450
Citizens Financial Group
CFG
$30.1B
$1.77M 0.01%
65,873
+5,107
+8% +$146K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.